Tessera Names Romanelli CEO in Pre-Data Succession
Tessera Therapeutics appointed Joseph Romanelli as president and chief executive officer, succeeding Michael Severino, who had led the Flagship-founded Gene Writing company since June 2022. Romanelli also joins Tessera’s board and Flagship Pioneering as…
